Clinical Trial Update: Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes

View source ↗

Summary

Clinical Trial Update detailing a completed individual patient data meta-analysis comparing continuous subcutaneous insulin infusion (CSII) with multiple daily …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: King's College London | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED